The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wagner Heidi L since 2016.
The trader's CIK number is 1655029.
At the time of the last reporting, Wagner Heidi L was the SVP, Global Government Affairs of Alexion Pharmaceuticals, Inc.. (stock ticker symbol ALXN).
Also see all insider trading activities at Alexion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ALXN | 0 | $0 | 3,127 | $366,441 | 0 | $0 |
| 2017 | ALXN | 0 | $0 | 3,046 | $391,318 | 0 | $0 |
| 2016 | ALXN | 0 | $0 | 2,562 | $357,263 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-27 | ALXN | Sale | 244 | 120.72 | 29,455 |
| 2018-02-28 | ALXN | Sale | 454 | 118.61 | 53,848 |
| 2018-02-08 | ALXN | Sale | 1,774 | 116.31 | 206,333 |
| 2018-02-05 | ALXN | Sale | 655 | 117.26 | 76,805 |
| 2017-10-02 | ALXN | Sale | 120 | 140.00 | 16,800 |
| 2017-02-27 | ALXN | Sale | 358 | 131.20 | 46,969 |
| 2017-02-28 | ALXN | Sale | 480 | 131.70 | 63,215 |
| 2017-03-01 | ALXN | Sale | 156 | 132.50 | 20,670 |
| 2017-02-06 | ALXN | Sale | 1,710 | 125.86 | 215,229 |
| 2017-02-07 | ALXN | Sale | 222 | 128.09 | 28,435 |
| 2016-11-14 | ALXN | Sale | 59 | 115.10 | 6,790 |
| 2016-10-03 | ALXN | Sale | 120 | 122.41 | 14,689 |
| 2016-08-08 | ALXN | Sale | 222 | 137.14 | 30,445 |
| 2016-05-13 | ALXN | Sale | 53 | 138.65 | 7,348 |
| 2016-02-08 | ALXN | Sale | 942 | 138.63 | 130,586 |
| 2016-02-04 | ALXN | Sale | 169 | 144.60 | 24,438 |
| 2016-02-05 | ALXN | Sale | 997 | 143.40 | 142,967 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wagner Heidi L (SVP, Global Government Affairs of Alexion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.